Skip to content
Saturday 5 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,831.09
0.00%
DAX
26,046.40
+0.17%
CAC 40
8,278.77
-0.09%
STOXX 50
6,392.93
+0.16%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 03 December 2014 10:28 am  |  Updated:  Friday 07 June 2019 5:45 pm

Parkinson’s app uMotif is the first app to be prescribed on the NHS

By: Emma Haslett

Add as a preferred source on Google

The NHS has just started prescribing its first app – from now on, patients with conditions such as diabetes, heart failure and Parkinsons can use uMotif, developed by a London-based startup, to monitor their health,

The app works by monitoring patients' blood pressure, blood glucose – and even includes a pedometer. Using the data it gets from them, it can issue patients with reminders, and help doctors to assess how well they are doing between appointments. To get access to it, patients are given a code on their prescription, and they can then download it from the iTunes or Android app store.

With the popularity of apps like MyFitnessPal, not to mention FitBug-style activity trackers, the logging of daily activity has become a pretty common thing. uMotif chief executive Bruce Hellman said we're at the "tipping point where digital health is about to start exploding and technology can really help to put people at the heart of their care".

At the moment, the app is being trialled for treatment of Parkinson's and diabetes, but it will be widened out across 17 NHS organisations. The idea is that it helps clinicians to develop on the NHS National Information Board's plans to "put patents at the centre of their care using technology" (although we'd hope patients were at the centre of their care already…).

The app can even link in with other healthcare applications, like Microsoft HealthVault. So following that £12bn IT bungle which crippled the NHS back in 2011, it looks like the service is finally getting its teeth into technology…

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NHS

Trending Articles

  • Jenrick pledges to raise tax-free personal allowance to £15,000

  • Beer, kits, hospitality and stadia can take Women’s Super League to greater heights

  • Virgin Atlantic ends British Airways grip on Team GB partnership

  • Electra/Persona at the National Theatre review: A dull mash-up of Sophocles and Bergman

  • Dazn National League row: Club in ‘poodles’ rant as owner calls for end to broadcast deal

More from Morning Wire

  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
  • New Drill-Free Treatment Helps Patients to Feel at Ease in the Dentist Chair

    Business Wire
  • Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization

    Business Wire
  • Limbic Becomes First AI-Led Mental Healthcare Company Selected for FDA TEMPO

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook